Huub C Gelderblom - Fred Hutch Cancer Center

基本信息

Career Trajectory

Bio

Staff Physician, Protocol Team Lead at HIV Vaccine Trials Network (HVTN) and COVID-19 Prevention Network (CoVPN) at Fred Hutchinson Cancer Research Center https://www.linkedin.com/in/huub-c-gelderblom-md-phd-mph-a52a646/

Research Interests

Papers共 47 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Immune Correlates Analysis of the Imbokodo (HVTN 705/HPX2008) Efficacy Trial of a Mosaic HIV-1 Vaccine Regimen Evaluated in Southern African People Assigned Female Sex at Birth: a Two-Phase Case-Control Study

EBioMedicine（2024）

Cited0Views0WOSBibtex

The Potential of Broadly Neutralizing Antibodies for HIV Prevention

Huub C. Gelderblom,Lawrence Corey,Dan H. Barouch

Journal of the International AIDS Societyno. 5 (2024): e26257-e26257

Cited0Views0WOSBibtex

Is HIV Epidemic Control by 2030 Realistic

Chris Beyrer,Georgia D Tomaras,Huub C Gelderblom,Glenda E Gray,Holly E Janes,Linda-Gail Bekker,Gregorio Millett,Giuseppe Pantaleo,Susan Buchbinder,Lawrence Corey

The lancet HIVno. 7 (2024): e489-e494

Cited0Views0WOSBibtex

Application of the SLAPNAP Statistical Learning Tool to Broadly Neutralizing Antibody HIV Prevention Research

Brian D. Williamson,Craig A. Magaret,Shelly Karuna,Lindsay N. Carpp,Huub C. Gelderblom,Yunda Huang,David Benkeser,Peter B. Gilbert

ISCIENCEno. 9 (2023)

Cited0Views0WOSBibtex

Safety, Pharmacokinetics and Antiviral Activity of PGT121, a Broadly Neutralizing Monoclonal Antibody Against HIV-1: a Randomized, Placebo-Controlled, Phase 1 Clinical Trial

Nature medicine（2021）

Cited43Views0WOSNATUREBibtex

Acceptability and Tolerability of Repeated Intramuscular Electroporation of Multi-antigenic HIV (HIVMAG) DNA Vaccine among Healthy African Participants in a Phase 1 Randomized Controlled Trial

Juliet Mpendo,Gaudensia Mutua,Annet Nanvubya,Omu Anzala,Julien Nyombayire,Etienne Karita,Len Dally,Drew Hannaman,Matt Price,Patricia E. Fast,Frances Priddy,Huub C. Gelderblom,Nancy K. Hills

PLoS ONE（2020）

Cited10Views0WOSBibtex

A003 Protocol - A Phase 1, Randomized, Blinded, Dose-Escalation Study of Raav1-Pg9dp Recombinant AAV Vector Coding for PG9 Antibody in Healthy Male Adults

Frances Priddy,David Lewis,Huub C. Gelderblom,Hanaa A. Hassanin,Claire Streatfield,Celia C. LaBranche,Jonathan Hare,Josephine H. Cox, Leonard G. Dally, Daryl Bendel,David C. Montefiori,Eddy Sayeed,Jim Ackland,Jill Gilmour, Bruce C. Schnepp,Fraser Wright,Philip J. Johnson

openalex（2019）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn